GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » Cyclically Adjusted PS Ratio

Hualan Biological Engineering (SZSE:002007) Cyclically Adjusted PS Ratio : 8.94 (As of Jun. 09, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Hualan Biological Engineering Cyclically Adjusted PS Ratio?

As of today (2024-06-09), Hualan Biological Engineering's current share price is ¥17.79. Hualan Biological Engineering's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥1.99. Hualan Biological Engineering's Cyclically Adjusted PS Ratio for today is 8.94.

The historical rank and industry rank for Hualan Biological Engineering's Cyclically Adjusted PS Ratio or its related term are showing as below:

SZSE:002007' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 8.94   Med: 20.48   Max: 55.5
Current: 8.94

During the past years, Hualan Biological Engineering's highest Cyclically Adjusted PS Ratio was 55.50. The lowest was 8.94. And the median was 20.48.

SZSE:002007's Cyclically Adjusted PS Ratio is ranked worse than
64.68% of 504 companies
in the Biotechnology industry
Industry Median: 5.47 vs SZSE:002007: 8.94

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Hualan Biological Engineering's adjusted revenue per share data for the three months ended in Mar. 2024 was ¥0.430. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥1.99 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hualan Biological Engineering Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Hualan Biological Engineering's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hualan Biological Engineering Cyclically Adjusted PS Ratio Chart

Hualan Biological Engineering Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.56 31.59 18.99 12.98 11.31

Hualan Biological Engineering Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.32 12.53 11.65 11.31 10.14

Competitive Comparison of Hualan Biological Engineering's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Hualan Biological Engineering's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hualan Biological Engineering's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hualan Biological Engineering's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Hualan Biological Engineering's Cyclically Adjusted PS Ratio falls into.



Hualan Biological Engineering Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Hualan Biological Engineering's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=17.79/1.99
=8.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hualan Biological Engineering's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Hualan Biological Engineering's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.43/115.2271*115.2271
=0.430

Current CPI (Mar. 2024) = 115.2271.

Hualan Biological Engineering Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.138 98.200 0.162
201409 0.242 98.900 0.282
201412 0.152 99.000 0.177
201503 0.164 99.900 0.189
201506 0.198 99.500 0.229
201509 0.250 100.500 0.287
201512 0.199 100.600 0.228
201603 0.227 102.200 0.256
201606 0.245 101.400 0.278
201609 0.303 102.400 0.341
201612 0.291 102.600 0.327
201703 0.297 103.200 0.332
201706 0.262 103.100 0.293
201709 0.360 104.100 0.398
201712 0.387 104.500 0.427
201803 0.310 105.300 0.339
201806 0.529 104.900 0.581
201809 0.690 106.600 0.746
201812 0.651 106.500 0.704
201903 0.382 107.700 0.409
201906 0.388 107.700 0.415
201909 0.678 109.800 0.712
201912 0.590 111.200 0.611
202003 0.370 112.300 0.380
202006 0.391 110.400 0.408
202009 0.925 111.700 0.954
202012 1.072 111.500 1.108
202103 0.341 112.662 0.349
202106 0.365 111.769 0.376
202109 1.137 112.215 1.168
202112 0.578 113.108 0.589
202203 0.351 114.335 0.354
202206 0.935 114.558 0.940
202209 0.685 115.339 0.684
202212 0.500 115.116 0.500
202303 0.483 115.116 0.483
202306 0.386 114.558 0.388
202309 1.276 115.339 1.275
202312 0.783 114.781 0.786
202403 0.430 115.227 0.430

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hualan Biological Engineering  (SZSE:002007) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Hualan Biological Engineering Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Hualan Biological Engineering's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hualan Biological Engineering (SZSE:002007) Business Description

Traded in Other Exchanges
N/A
Address
No. A1 Hualan Avenue, Henan Province, Xinxiang, CHN, 453003
Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.
Executives
An Kang Directors, executives
Pan Ruo Wen Executives
An Wen Qi Executives
Wang Qi Ping Directors, executives
Fan Bei Directors, executives
Ma Xiao Wei Executives
Xie Jun Min Directors, executives
Zhang Bao Xian Executives
Lv Cheng Yu Securities Affairs Representative
Zhang Jin Gang Independent director
Wang Li Ting Independent director
Ma Li Supervisors
Sun Zhen Guo Supervisors
Chen Lei Shan Supervisors
Yang Bao Ping Supervisors

Hualan Biological Engineering (SZSE:002007) Headlines

No Headlines